A RETROSPECTIVE ANALYSIS OF HEPATITIS A INFECTION IN DADRA & NAGAR HAVELI.
Main Article Content
Keywords
Hepatitis A, Seroprevalence, Viral Hepatitis
Abstract
Background: It is crucial to research the long-term trends of the Hepatitis A (HAV) virus given the diversity of socioeconomic and demographic factors in a large country like India. Their seroprevalence and long-term trends in a tertiary care facility in Dadra and Nagar Haveli, which is close to Gujarat and Maharashtra, are described in this study.
Methods: Six years were covered by the current retrospective observational study (January 2019 to December 2024). IgM antibodies against HAV were detected through serological testing utilizing the enzyme-linked immunosorbent assay.
Results: A total of 1147 samples were tested during the study period, of which 149 (12.99%) were reactive for Anti-HAV IgM antibody. Among HAV group, 83 (55.70 %) were less than or equal to 12 years, 58 (38.92 %) were 13 to 60 years, and 8 (5.36 %) were more than 61 years. At the same time fluctuation was reported in the serum total bilirubin along with SGOT (Serum Glutamic Oxaloacetic Transaminase) AND SGPT (Serum Glutamic Pyruvic Transaminase).
Conclusions: The shift in seroprevalence among children, along with an increasing trend of the number of cases reporting to the hospital, warrants active surveillance of HAV. Intervention, such as universal childhood vaccination program, must be properly implemented and time correctly.
References
2. Jacobsen, K. H. (2018). Globalization and the changing epidemiology of hepatitis A virus. Cold Spring Harbor Perspectives in Medicine, 8(10), a031716. https://doi.org/10.1101/cshperspect.a031716
3. Sander, A.-L., Corman, V. M., Lukashev, A. N., Drexler, J. F., Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Virology, German Center for Infection Research (DZIF), Martsinovsky Institute of Medical Parasitology, Tropical and Vector Borne Diseases, Sechenov University, & Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Preparations. (2018). Evolutionary origins of enteric hepatitis viruses. In Cold Spring Harb Perspect Med. https://doi.org/10.1101/cshperspect.a031690
4. Barathidasan R, Vanathy K, Venkatesh K, Sharmila FM, Dhodapkar R. Epidemiological and molecular investigation of a hepatitis A outbreak in Tamil Nadu, Southern India. J Infect Dev Ctries. 2020 Dec 31;14(12):1475-1479. doi: 10.3855/jidc.12045. PMID: 33378294.
5. Tan EM, Marcelin JR, Virk A. Pre-travel counseling for immunocompromised travelers: A 12-year single-center retrospective review. Infect Dis Health. 2019 Feb;24(1):13-22. doi: 10.1016/j.idh.2018.09.083. Epub 2018 Oct 26. PMID: 30541695.
6. Jain, A., Prakash, S., Shukla, S., Shukla, R., Bhagat, A., & Srivastava, S. (2020). Molecular characterization of hepatitis A virus circulating in Uttar Pradesh, India: A hospital-based study. The Indian Journal of Medical Research, 151(4), 375. https://doi.org/10.4103/ijmr.ijmr_429_18
7. Lanford, R. E., Feng, Z., Chavez, D., Guerra, B., Brasky, K. M., Zhou, Y., Yamane, D., Perelson, A. S., Walker, C. M., & Lemon, S. M. (2011). Acute hepatitis A virus infection is associated with a limited type I interferon response and persistence of intrahepatic viral RNA. Proceedings of the National Academy of Sciences, 108(27), 11223–11228. https://doi.org/10.1073/pnas.1101939108
8. Feng, Z., Hensley, L., McKnight, K. L., Hu, F., Madden, V., Ping, L., Jeong, S., Walker, C., Lanford, R. E., & Lemon, S. M. (2013). A pathogenic picornavirus acquires an envelope by hijacking cellular membranes. Nature, 496(7445), 367–371. https://doi.org/10.1038/nature12029
9. Drexler, J. F., Corman, V. M., Lukashev, A. N., Van Den Brand, J. M. A., Gmyl, A. P., Brünink, S., Rasche, A., Seggewiβ, N., Feng, H., Leijten, L. M., Vallo, P., Kuiken, T., Dotzauer, A., Ulrich, R. G., Lemon, S. M., Drosten, C., Akoua-Koffi, C. G., Ameneiros, R. S., Goodman, S. M., . . . Wilkinson, D. A. (2015). Evolutionary origins of hepatitis A virus in small mammals. Proceedings of the National Academy of Sciences, 112(49), 15190–15195. https://doi.org/10.1073/pnas.1516992112
10. World Health Organisation. Hepatitis A fact sheet, https://www. who.int/news-room/fact-sheets/detail/hepatitis-a ; 2020 [accessed 17 August 2020].
11. CUTHBERT, J. A. (2001). Hepatitis A: old and new. In American Society for Microbiology, CLINICAL MICROBIOLOGY REVIEWS (No. 1; Vols. 14–14, pp. 38–58). American Society for Microbiology. https://doi.org/10.1128/CMR.14.1.38-58.2001
12. Ndumbi, P., Freidl, G. S., Williams, C. J., Mårdh, O., Varela, C., Avellón, A., Friesema, I., Vennema, H., Beebeejaun, K., Ngui, S. L., Edelstein, M., Smith-Palmer, A., Murphy, N., Dean, J., Faber, M., Wenzel, J., Kontio, M., Müller, L., Midgley, S. E., . . . Severi, E. (2018). Hepatitis A outbreak disproportionately affecting men who have sex with men (MSM) in the European Union and European Economic Area, June 2016 to May 2017. Eurosurveillance, 23(33). https://doi.org/10.2807/1560-7917.es.2018.23.33.1700641
13. Foster, M., Ramachandran, S., Myatt, K., Donovan, D., Bohm, S., Fiedler, J., Barbeau, B., US Department of Health and Human Services/Centers for Disease Control and Prevention, Collins, J., Thoroughman, D., McDonald, E., Ballard, J., Eason, J., & Jorgensen, C. (2018). Hepatitis A Virus Outbreaks Associated with Drug Use and Homelessness — California, Kentucky, Michigan, and Utah, 2017. In Morbidity and Mortality Weekly Report (Vol. 67, Issue 43).
14. Jacobsen, K. H., & Wiersma, S. T. (2010). Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Vaccine, 28(41), 6653–6657. https://doi.org/10.1016/j.vaccine.2010.08.037
15. Jeong SH, Lee HS. Hepatitis A: clinical manifestations and manage ment. Intervirology 2010;53:15-9.
16. Clinical course and management of acute hepatitis A infection in adults. (2012). September-October, 11(5), 652–657.
17. Webb, G., Kelly, S., Dalton, H. R., & Elsevier. (2020). Hepatitis A and hepatitis E: clinical and epidemiological features, diagnosis, treatment, and prevention. In Clinical Microbiology Newsletter (Vol. 42, Issue 21) [Journal-article]. https://www.cmnewsletter.com
18. Bansal, Y., Singla, N., Garg, K., Sharma, G., Gill, M., & Chander, J. (2022). Seroprevalence of hepatitis A and hepatitis E in patients at a teaching hospital of northern India over a period of 8 years. Journal of Family Medicine and Primary Care, 11(2), 567–572. https://doi.org/10.4103/jfmpc.jfmpc_1212_21
19. Aggarwal, R., Goel, A., & Wolters Kluwer Health, Inc. (2015). Hepatitis A: epidemiology in resource-poor countries. In Current Opinion (pp. 488–496) [Journal-article]. Wolters Kluwer Health, Inc. https://www.co-infectiousdiseases.com
20. Mitra, M., Arankalle, V., Bhave, S., Ghosh, A., Balasubramanian, S., Chitkara, A., Choudhury, J., Chatterjee, S., Kadhe, G., Mane, A., & Roy, S. (2014). Changing epidemiology of hepatitis A virus in Indian children. Vaccine Development and Therapy, 7. https://doi.org/10.2147/vdt.s53324
21. Agrawal, A., Singh, S., Kolhapure, S., Hoet, B., Arankalle, V., & Mitra, M. (2019). Increasing Burden of Hepatitis A in Adolescents and Adults and the Need for Long-Term Protection: A Review from the Indian Subcontinent. Infectious Diseases and Therapy, 8(4), 483–497. https://doi.org/10.1007/s40121-019-00270-9
22. Palewar, M. S., Joshi, S., Choudhary, G., Das, R., Sadafale, A., & Karyakarte, R. (2022). Prevalence of Hepatitis A virus (HAV) and Hepatitis E virus (HEV) in patients presenting with acute viral hepatitis: A 3-year retrospective study at a tertiary care Hospital in Western India. Journal of Family Medicine and Primary Care, 11(6), 2437–2441. https://doi.org/10.4103/jfmpc.jfmpc_1746_21
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Dr Kamaljeet
Tutor, Dept of Microbiology, NAMO Medical Education & Research Institute, Silvassa
Dr Nadeem Ameen
Laboratory Physician, Specialist Microbiology, Dhaman Health Assurance Hospital Ahmadi Kuwait
Dr Sarita Shrivastava
Associate Professor, Dept of Pathology, MGM Medical College Nerul Navi Mumbai
Dr Mohd Aadam Bin Najeeb
Assistant Professor, Dept of Microbiology, NAMO Medical Education & Research Institute, Silvassa
Ms Pratiksha Dhamal
Tutor, Dept of Pharmacology, NAMO Medical Education & Research Institute, Silvassa
Dr Narayan Kamath
Professor, Dept of Microbiology, NAMO Medical Education & Research Institute, Silvassa